Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1886 1
1929 1
1947 1
1948 2
1949 2
1950 10
1951 1
1952 9
1953 5
1954 6
1955 10
1956 11
1957 18
1958 19
1959 6
1960 16
1961 20
1962 15
1963 23
1964 9
1965 4
1966 18
1967 19
1968 29
1969 30
1970 21
1971 33
1972 28
1973 23
1974 20
1975 19
1976 20
1977 8
1978 13
1979 11
1980 10
1981 12
1982 11
1983 11
1984 18
1985 13
1986 12
1987 13
1988 10
1989 15
1990 18
1991 24
1992 18
1993 16
1994 18
1995 17
1996 16
1997 14
1998 11
1999 11
2000 13
2001 15
2002 17
2003 20
2004 22
2005 13
2006 19
2007 21
2008 37
2009 42
2010 37
2011 51
2012 60
2013 38
2014 43
2015 40
2016 48
2017 55
2018 64
2019 57
2020 49
2021 62
2022 46
2023 56
2024 55
2025 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,662 results

Results by year

Filters applied: . Clear all
Page 1
Disease diagnostics using machine learning of B cell and T cell receptor sequences.
Zaslavsky ME, Craig E, Michuda JK, Sehgal N, Ram-Mohan N, Lee JY, Nguyen KD, Hoh RA, Pham TD, Röltgen K, Lam B, Parsons ES, Macwana SR, DeJager W, Drapeau EM, Roskin KM, Cunningham-Rundles C, Moody MA, Haynes BF, Goldman JD, Heath JR, Chinthrajah RS, Nadeau KC, Pinsky BA, Blish CA, Hensley SE, Jensen K, Meyer E, Balboni I, Utz PJ, Merrill JT, Guthridge JM, James JA, Yang S, Tibshirani R, Kundaje A, Boyd SD. Zaslavsky ME, et al. Among authors: merrill jt. Science. 2025 Feb 21;387(6736):eadp2407. doi: 10.1126/science.adp2407. Epub 2025 Feb 21. Science. 2025. PMID: 39977494 Free PMC article.
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Morand E, Pike M, Merrill JT, van Vollenhoven R, Werth VP, Hobar C, Delev N, Shah V, Sharkey B, Wegman T, Catlett I, Banerjee S, Singhal S. Morand E, et al. Among authors: merrill jt. Arthritis Rheumatol. 2023 Feb;75(2):242-252. doi: 10.1002/art.42391. Epub 2022 Nov 11. Arthritis Rheumatol. 2023. PMID: 36369798 Free PMC article. Clinical Trial.
Reply.
Merrill JT. Merrill JT. Arthritis Rheumatol. 2022 Jun;74(6):1093. doi: 10.1002/art.42096. Epub 2022 Apr 19. Arthritis Rheumatol. 2022. PMID: 35188717 No abstract available.
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.
Wu D, Li J, Xu D, Merrill JT, van Vollenhoven RF, Liu Y, Hu J, Li Y, Li F, Huang C, Wang G, Li X, Zhao J, Zhao D, Huang C, Liu H, Wei W, Shi G, Lu F, Zuo X, Bi L, Li Z, Wang X, Zhang M, Tie N, Li J, Mo H, Fang J, Bao C, Zhang F. Wu D, et al. Among authors: merrill jt. Ann Rheum Dis. 2024 Mar 12;83(4):475-487. doi: 10.1136/ard-2023-224854. Ann Rheum Dis. 2024. PMID: 38129117 Free PMC article. Clinical Trial.
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer.
Klingbeil O, Skopelitis D, Tonelli C, Yoshimoto T, Alpsoy A, Panepinto MC, Minicozzi F, Merrill JR, Cafiero AM, Aggarwal D, Russo S, Ha T, Demerdash OE, Wee TL, Spector DL, Lyons SK, Tuveson DA, Cifani P, Vakoc CR. Klingbeil O, et al. Among authors: merrill jr. Cancer Discov. 2024 Dec 2;14(12):2471-2488. doi: 10.1158/2159-8290.CD-23-1529. Cancer Discov. 2024. PMID: 39058094 Free PMC article.
Reply.
Merrill JT, Gaudreau MC, D'Silva KM. Merrill JT, et al. Arthritis Rheumatol. 2025 Aug;77(8):1108-1109. doi: 10.1002/art.43123. Epub 2025 Feb 14. Arthritis Rheumatol. 2025. PMID: 39953664 No abstract available.
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial.
Merrill JT, Tanaka Y, D'Cruz D, Vila-Rivera K, Siri D, Zeng X, Saxena A, Aringer M, D'Silva KM, Cheng L, Mohamed MF, Siovitz L, Bhatnagar S, Gaudreau MC, Doan TT, Friedman A. Merrill JT, et al. Arthritis Rheumatol. 2024 Oct;76(10):1518-1529. doi: 10.1002/art.42926. Epub 2024 Aug 7. Arthritis Rheumatol. 2024. PMID: 38923871 Clinical Trial.
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Choi MY, Chen I, Clarke AE, Fritzler MJ, Buhler KA, Urowitz M, Hanly J, St-Pierre Y, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Buyon JP, Sontag D, Costenbader KH. Choi MY, et al. Among authors: merrill jt. Ann Rheum Dis. 2023 Jul;82(7):927-936. doi: 10.1136/ard-2022-223808. Epub 2023 Apr 21. Ann Rheum Dis. 2023. PMID: 37085289 Free PMC article.
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Vital EM, Merrill JT, Morand EF, Furie RA, Bruce IN, Tanaka Y, Manzi S, Kalunian KC, Kalyani RN, Streicher K, Abreu G, Tummala R. Vital EM, et al. Among authors: merrill jt. Ann Rheum Dis. 2022 Jul;81(7):951-961. doi: 10.1136/annrheumdis-2021-221425. Epub 2022 Mar 25. Ann Rheum Dis. 2022. PMID: 35338035 Free PMC article. Clinical Trial.
1,662 results